GMOV · ARCA · ETF
GMO US Value ETF (GMOV) Price, Holdings & Fees
GMO US Value ETF (GMOV) closed at $559.49 on Oct 9, 2026, down 1.14% from the previous close of $565.94.
Share price, past year
1Y +3.28%Monthly closing prices
| Date | Close |
|---|---|
| Oct 9, 2026 | $559.49 |
| Sep 30, 2026 | $578.68 |
| Aug 31, 2026 | $605.44 |
| Jul 31, 2026 | $583.77 |
| Jun 30, 2026 | $578.39 |
| May 29, 2026 | $580.43 |
| Apr 30, 2026 | $569.84 |
| Mar 31, 2026 | $547.28 |
| Feb 27, 2026 | $528.44 |
| Jan 30, 2026 | $516.17 |
| Dec 31, 2025 | $484.96 |
| Nov 28, 2025 | $524.04 |
| Oct 31, 2025 | $524.70 |
Key statistics
- Expense ratio
- 0.50%
- as of Feb 28, 2026
- Net assets
- $90.9M
- as of May 31, 2026
- Holdings
- 165
- as of May 31, 2026
- 52-week range
- $479.20 – $612.85
GMO US Value ETF's expense ratio is 0.50%: $50.00 a year on $10,000 invested.
Holdings
GMO US Value ETF held 165 investments worth $90.92M as of May 31, 2026. Its largest holding was Meta Platforms Inc, at 5.18% of the fund.
| # | Holding | % of fund | Value |
|---|---|---|---|
| 1 | Meta Platforms Inc | 5.18% | $4.71M |
| 2 | Alphabet Inc | 3.89% | $3.54M |
| 3 | QUALCOMM Inc | 3.36% | $3.06M |
| 4 | Merck & Co Inc | 2.73% | $2.49M |
| 5 | Exxon Mobil Corp | 2.58% | $2.35M |
| 6 | Verizon Communications Inc | 2.37% | $2.15M |
| 7 | Bank of America Corp | 2.19% | $2.00M |
| 8 | Pfizer Inc | 2.10% | $1.91M |
| 9 | UnitedHealth Group Inc | 2.02% | $1.84M |
| 10 | Johnson & Johnson | 1.98% | $1.80M |
| 11 | Comcast Corp | 1.89% | $1.71M |
| 12 | JPMorgan Chase & Co | 1.70% | $1.55M |
| 13 | Bristol-Myers Squibb Co | 1.66% | $1.51M |
| 14 | AT&T Inc | 1.63% | $1.48M |
| 15 | Procter & Gamble Co/The | 1.54% | $1.40M |
| 16 | Cigna Group/The | 1.53% | $1.39M |
| 17 | Target Corp | 1.50% | $1.36M |
| 18 | United Parcel Service Inc | 1.47% | $1.34M |
| 19 | Citigroup Inc | 1.33% | $1.21M |
| 20 | Progressive Corp/The | 1.30% | $1.18M |
| 21 | EOG Resources Inc | 1.28% | $1.16M |
| 22 | International Business Machines Corp | 1.24% | $1.12M |
| 23 | CVS Health Corp | 1.21% | $1.10M |
| 24 | Regeneron Pharmaceuticals Inc | 1.19% | $1.08M |
| 25 | Allstate Corp/The | 1.16% | $1.05M |
Top 25 of 165 holdings, as of May 31, 2026. Percentages are of the fund's net assets.
What the fund owns
| Asset type | % of fund |
|---|---|
| Stocks | 98.78% |
| Cash and short-term investments | 1.09% |
| Country | % of fund |
|---|---|
| United States | 97.82% |
| Bermuda | 0.72% |
| Switzerland | 0.68% |
| Jersey | 0.26% |
| Netherlands | 0.20% |
| Ireland | 0.19% |
Shares of net assets from the fund's N-PORT report. Funds that borrow can add up to more than 100%, with borrowing (such as repurchase agreements) shown as a negative share.
Monthly total returns
Over the 3 months to May 31, 2026, GMO US Value ETF's total return was +4.22%, as reported to the SEC.
| Month | Total return |
|---|---|
| May 31, 2026 | +1.64% |
| Apr 30, 2026 | +6.04% |
| Mar 31, 2026 | −3.30% |
The fund's own total returns as reported to the SEC (N-PORT), including reinvested distributions. Not the sample prices above.
Fund profile
- Name
- GMO US Value ETF
- Ticker
- GMOV
- Exchange
- ARCA
- Fund type
- ETF
- Trust
- GMO ETF Trust
- SEC series ID
- S000088551
- SEC CIK
- 0001981627
- Fractional shares
- No
Recent SEC filings
- Jul 29, 2026
- 485BPOSProspectus updateJun 30, 2026
- May 7, 2026
- Mar 5, 2026
- 485BPOSProspectus updateOct 28, 2025
- Sep 5, 2025
- 485BPOSProspectus updateAug 20, 2025
- Mar 7, 2025
Shareholder reports and prospectuses are filed by GMO ETF Trust, the trust behind GMO US Value ETF, and cover all of its funds.
Frequently asked questions
What is GMOV's price?
GMO US Value ETF (GMOV) closed at $559.49 on Oct 9, 2026, down 1.14% from the previous close of $565.94.
What is GMOV's expense ratio?
GMO US Value ETF's expense ratio is 0.50%: $50.00 a year on $10,000 invested.
What does GMOV hold?
GMO US Value ETF held 165 investments worth $90.92M as of May 31, 2026. Its largest holding was Meta Platforms Inc, at 5.18% of the fund. Its five largest holdings were Meta Platforms Inc, Alphabet Inc, QUALCOMM Inc, Merck & Co Inc, Exxon Mobil Corp.
How has GMOV performed?
Over the 3 months to May 31, 2026, GMO US Value ETF's total return was +4.22%, as reported to the SEC.
Sources and methodology
Holdings, net assets and monthly returns come from the fund's N-PORT filing with the SEC, as of May 31, 2026 (filed Jul 29, 2026). The expense ratio is from the fund's prospectus or shareholder report, as of Feb 28, 2026. Prices are generated sample data for development. Data sources and disclosures